Alshalalfa, Mohammed http://orcid.org/0000-0001-8405-3035
Seldon, Crystal
Franco, Idalid
Vince, Randy http://orcid.org/0000-0002-7779-473X
Carmona, Ruben
Punnen, Sanoj
Kaochar, Salma http://orcid.org/0000-0001-9437-8829
Dess, Robert http://orcid.org/0000-0003-2331-3758
Kishan, Amar http://orcid.org/0000-0002-7437-6591
Spratt, Daniel E. http://orcid.org/0000-0002-5973-4741
Sharma, Janaki
Dal Pra, Alan http://orcid.org/0000-0002-1648-6557
Pollack, Alan
Abramowitz, Matthew C.
Mahal, Brandon A. http://orcid.org/0000-0001-5406-3232
Funding for this research was provided by:
Prostate Cancer Foundation
Article History
Received: 22 April 2021
Revised: 17 November 2021
Accepted: 13 December 2021
First Online: 12 January 2022
Competing interests
: Dr. Mahal is funded by the Prostate Cancer Foundation-American Society for Radiation Oncology Award to End Prostate Cancer (grant support). Dr. Franco is funded by an NIH NCI Center to Reduce Cancer Health Disparities Diversity Supplement, and ACRO Luther Brady Educational Award (grant support). Dr. Spratt has received personal fees: Janssen, Blue Earth, Boston Scientific, AstraZeneca, and funding from Janssen. The remaining authors declare that they have no conflicts of interest.